21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA

Introduction: Sentinel lymph node biopsy (SLNB) is a standard procedure at the OncologyInstitute of Vojvodina since 1999 and during this period we have done more than 1700 biopsies. The aim of this study was to present our results in SLNB in breast cancer surgery. Materials and methods: This retr...

ver descrição completa

Detalhes bibliográficos
Main Authors: Selakovic Vladimir, Ranisavljevic Milan, Lukic Dejan, Djuric Mladen
Formato: Artigo
Idioma:English
Publicado em: Association of medical doctors Sanamed Novi Pazar 2021-05-01
Colecção:Sanamed
Assuntos:
Acesso em linha:http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/471/253
_version_ 1827337089734148096
author Selakovic Vladimir
Ranisavljevic Milan
Lukic Dejan
Djuric Mladen
author_facet Selakovic Vladimir
Ranisavljevic Milan
Lukic Dejan
Djuric Mladen
author_sort Selakovic Vladimir
collection DOAJ
description Introduction: Sentinel lymph node biopsy (SLNB) is a standard procedure at the OncologyInstitute of Vojvodina since 1999 and during this period we have done more than 1700 biopsies. The aim of this study was to present our results in SLNB in breast cancer surgery. Materials and methods: This retrospective study was performed at the Department for Surgical Oncology at the Vojvodina Institute of Oncology in the period from January 1999 to December 2019. The study included 1762 patients who had undergone SLNB. The mean duration of the follow-up period was 121.89 months. All patients were women with clinically T1-2N0-1M0 breast cancer. Preoperatively, all patients were administered dual contrast media, radiotracer, and blue dye. Results: The majority of tumors were T1c (955 (54.18%). The mean number of extirpated sentinel lymph nodes (SLN) in both groups was 1.84. In 199 (36.72%) patients SLN was the only metastatic lymph node in the axilla. Micro metastases were found in 113 (21.03%) patients. The overall diagnostic accuracy of SLNB was 96%. Conclusion: Axillary SLN can serve as a reliable predictor of negativity of other ipsilateral axillary nodes. Micro metastases in the SLN are not an indication for complete axillary lymph node dissection.
first_indexed 2024-03-07T18:44:52Z
format Article
id doaj.art-d5ed04f9583c44848077f48351294a92
institution Directory Open Access Journal
issn 1452-662X
2217-8171
language English
last_indexed 2024-03-07T18:44:52Z
publishDate 2021-05-01
publisher Association of medical doctors Sanamed Novi Pazar
record_format Article
series Sanamed
spelling doaj.art-d5ed04f9583c44848077f48351294a922024-03-02T03:04:19ZengAssociation of medical doctors Sanamed Novi PazarSanamed1452-662X2217-81712021-05-01161656910.24125/sanamed.v16i1.47121 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINASelakovic Vladimir0Ranisavljevic Milan1Lukic Dejan2Djuric Mladen3Oncology Institute of Vojvodina, Department for operative oncology, Novi Sad, Serbia1. Oncology Institute of Vojvodina, Department for operative oncology, Novi Sad, Serbia; 2. Medical faculty of Novi Sad, University of Novi Sad, Novi Sad, Serbia1. Oncology Institute of Vojvodina, Department for operative oncology, Novi Sad, Serbia; 2. Medical faculty of Novi Sad, University of Novi Sad, Novi Sad, Serbia Oncology Institute of Vojvodina, Department for operative oncology, Novi Sad, SerbiaIntroduction: Sentinel lymph node biopsy (SLNB) is a standard procedure at the OncologyInstitute of Vojvodina since 1999 and during this period we have done more than 1700 biopsies. The aim of this study was to present our results in SLNB in breast cancer surgery. Materials and methods: This retrospective study was performed at the Department for Surgical Oncology at the Vojvodina Institute of Oncology in the period from January 1999 to December 2019. The study included 1762 patients who had undergone SLNB. The mean duration of the follow-up period was 121.89 months. All patients were women with clinically T1-2N0-1M0 breast cancer. Preoperatively, all patients were administered dual contrast media, radiotracer, and blue dye. Results: The majority of tumors were T1c (955 (54.18%). The mean number of extirpated sentinel lymph nodes (SLN) in both groups was 1.84. In 199 (36.72%) patients SLN was the only metastatic lymph node in the axilla. Micro metastases were found in 113 (21.03%) patients. The overall diagnostic accuracy of SLNB was 96%. Conclusion: Axillary SLN can serve as a reliable predictor of negativity of other ipsilateral axillary nodes. Micro metastases in the SLN are not an indication for complete axillary lymph node dissection.http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/471/253breast cancersentinel lymph nodecomplete axillary lymph node disection
spellingShingle Selakovic Vladimir
Ranisavljevic Milan
Lukic Dejan
Djuric Mladen
21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA
Sanamed
breast cancer
sentinel lymph node
complete axillary lymph node disection
title 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA
title_full 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA
title_fullStr 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA
title_full_unstemmed 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA
title_short 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA
title_sort 21 years after introducing sentinel lymph node biopsy in clinical praxis at the oncology institute of vojvodina
topic breast cancer
sentinel lymph node
complete axillary lymph node disection
url http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/471/253
work_keys_str_mv AT selakovicvladimir 21yearsafterintroducingsentinellymphnodebiopsyinclinicalpraxisattheoncologyinstituteofvojvodina
AT ranisavljevicmilan 21yearsafterintroducingsentinellymphnodebiopsyinclinicalpraxisattheoncologyinstituteofvojvodina
AT lukicdejan 21yearsafterintroducingsentinellymphnodebiopsyinclinicalpraxisattheoncologyinstituteofvojvodina
AT djuricmladen 21yearsafterintroducingsentinellymphnodebiopsyinclinicalpraxisattheoncologyinstituteofvojvodina